Journl Streamed
Talk to an expertWebsite
  • Introduction
  • Getting Started
    • Sandbox Access
    • On-Premise
    • Cloud
  • Overview
    • Why Journl Streamed?
    • Licensing & Support
    • Features
    • Solution Architecture and Usage
  • API
    • FHIR API
      • Accessing FHIR Data
      • CRUD
        • Create
        • Read
        • Update
          • Versioned Update
        • Patch
        • Delete
          • Versioned Delete
    • Batch Upsert
  • Services
    • Security & Access Control
    • FHIR Modeling, Profiles, and Standards
    • Careplan Creation
    • Analysis on Demand
      • Standard Process
      • Types of Analysis
    • Custom Resources
    • Monitoring & Maintenance
  • Storage
    • Database
      • Database schema
    • Backup and Restore
    • Indexes
  • Integrations
    • Data Ingestion and Decoupling
    • Subscriptions and Event Notifications
    • BI & Analytical tools
      • Power BI
      • Tableau
      • Jupyter Notebook
Powered by GitBook
On this page
  1. Services
  2. Analysis on Demand

Types of Analysis

  • Comparative Effectiveness Analysis:

    Comparative effectiveness analysis evaluates the relative effectiveness of different treatments or interventions in real-world clinical practice. It provides insights into which treatments work best across diverse patient populations, helping clinicians and policymakers make evidence-based decisions. This analysis is particularly valuable when assessing outcomes across varied patient demographics and clinical settings.

  • Patient Demographics and Treatment Pathways:

    By analyzing patient demographics and treatment pathways, we can identify subpopulations that derive the most benefit from specific treatments. This analysis is essential for driving personalized medicine approaches, ensuring that healthcare providers tailor treatments to the unique characteristics of patient groups, improving both efficacy and patient outcomes.

  • Outcome-Based Pricing Models:

    Outcome-based pricing models are increasingly relevant in healthcare, where reimbursement is linked to the real-world performance of a drug. This analysis connects drug usage data with patient outcomes, providing a solid foundation for pricing agreements that reflect the actual benefits achieved in clinical practice, rather than relying solely on controlled clinical trial results.

  • AI-Enhanced Predictive Analytics:

    Leveraging artificial intelligence, predictive analytics focuses on identifying patterns and predicting patient outcomes based on RWD. This AI-driven approach provides healthcare providers and pharmaceutical companies with deeper insights into the risks and benefits associated with various treatments, making it a crucial tool for both clinical decision-making and future research.

  • Health Economic Analyses:

    Health economic analyses assess the cost-effectiveness of treatments, helping payers and pharmaceutical companies determine whether a treatment provides value for the cost. This analysis is essential for supporting reimbursement decisions, market access strategies, and ensuring that healthcare resources are allocated efficiently.

PreviousStandard ProcessNextCustom Resources

Last updated 7 months ago